Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125338802 | 12533880 | 2 | F | 20120927 | 20160704 | 20160706 | 20160714 | EXP | FR-ABBVIE-16P-056-1669743-00 | ABBVIE | 78.62 | YR | M | Y | 0.00000 | 20160714 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125338802 | 12533880 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | Y | UNKNOWN | 18723 | TABLET | ||||||||
| 125338802 | 12533880 | 2 | SS | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | Y | UNKNOWN | 0 | TABLET | ||||||||
| 125338802 | 12533880 | 3 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Unknown | Y | UNKNOWN | 0 | 3 | G | QD | ||||||
| 125338802 | 12533880 | 4 | SS | TADENAN | PYGEUM | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 125338802 | 12533880 | 5 | SS | TADENAN | PYGEUM | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 125338802 | 12533880 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 125338802 | 12533880 | 7 | C | MODOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | 0 | ||||||||||||
| 125338802 | 12533880 | 8 | C | GALANTAMINE HYDROBROMIDE. | GALANTAMINE HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125338802 | 12533880 | 9 | C | PAROXETINE. | PAROXETINE | 1 | 0 | ||||||||||||
| 125338802 | 12533880 | 10 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125338802 | 12533880 | 11 | C | TIAPRIDAL | TIAPRIDE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125338802 | 12533880 | 1 | Product used for unknown indication |
| 125338802 | 12533880 | 2 | Product used for unknown indication |
| 125338802 | 12533880 | 3 | Lung disorder |
| 125338802 | 12533880 | 4 | Product used for unknown indication |
| 125338802 | 12533880 | 6 | Product used for unknown indication |
| 125338802 | 12533880 | 7 | Product used for unknown indication |
| 125338802 | 12533880 | 8 | Product used for unknown indication |
| 125338802 | 12533880 | 9 | Product used for unknown indication |
| 125338802 | 12533880 | 10 | Product used for unknown indication |
| 125338802 | 12533880 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125338802 | 12533880 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125338802 | 12533880 | Coma | |
| 125338802 | 12533880 | Epilepsy | |
| 125338802 | 12533880 | Status epilepticus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125338802 | 12533880 | 1 | 20120927 | 0 | ||
| 125338802 | 12533880 | 2 | 20120927 | 0 | ||
| 125338802 | 12533880 | 3 | 20120926 | 20120927 | 0 | |
| 125338802 | 12533880 | 4 | 20120927 | 0 |